Celecoxib is approved for a variety of clinical conditions, including:

1. Osteoarthritis:
   • Management of pain and inflammation associated with osteoarthritis.
2. Rheumatoid Arthritis:
   • Treatment of pain and inflammation in rheumatoid arthritis.
3. Acute Pain:
   • Management of acute pain, such as postoperative pain and musculoskeletal pain.
4. Ankylosing Spondylitis:
   • Treatment of pain and inflammation in ankylosing spondylitis.
5. Off-Label Uses:
   • Management of chronic pain conditions (e.g., low back pain).
   • Adjunctive therapy for dental pain.

The dosage of celecoxib varies depending on the indication, patient response, and tolerability. The following dosing guidelines are based on the British National Formulary (BNF) and clinical pharmacology references:

1. Osteoarthritis:
   • Adults: 200 mg once daily or 100 mg twice daily.
2. Rheumatoid Arthritis:
   • Adults: 100–200 mg twice daily.
3. Acute Pain:
   • Adults: 400 mg initially, followed by 200 mg twice daily as needed.
4. Ankylosing Spondylitis:
   • Adults: 200 mg once daily or 100 mg twice daily.

Important Considerations:

• Celecoxib is available in oral capsules.
• Dose adjustments may be necessary for patients with hepatic or renal impairment.
• Celecoxib should be taken with food to minimize gastrointestinal side effects.

Celecoxib is generally well-tolerated, but it is associated with a range of side effects, some of which can be serious. Common side effects include:

1. Gastrointestinal:
   • Nausea, dyspepsia, and abdominal pain.
   • Gastric ulcers and gastrointestinal bleeding (less common than with non-selective NSAIDs).
2. Cardiovascular:
   • Increased risk of myocardial infarction and stroke, particularly with long-term use or high doses.
3. Renal:
   • Acute kidney injury and interstitial nephritis (rare).
4. Other:
   • Headache, dizziness, and edema.

Serious Side Effects:

• Cardiovascular Events: Increased risk of thrombotic events, such as myocardial infarction and stroke.
• Hypersensitivity Reactions: Stevens-Johnson syndrome (SJS) and anaphylaxis (rare).

Hepatotoxicity: Elevated liver enzymes and, rarely, severe liver damage

Celecoxib requires careful monitoring and adherence to specific precautions to ensure patient safety:

1. Cardiovascular Risk:
   • Use with caution in patients with a history of cardiovascular disease. Regular monitoring of cardiovascular health is recommended.
2. Renal Impairment:
   • Use with caution in patients with impaired kidney function. Avoid use in severe renal impairment (CrCl <30 mL/min).
3. Hepatic Impairment:
   • Use with caution in patients with hepatic impairment. Avoid use in severe hepatic impairment.
4. Pregnancy and Lactation:
   • Celecoxib should be avoided during pregnancy, especially in the third trimester, due to the risk of premature closure of the ductus arteriosus. It is excreted in breast milk, so breastfeeding is generally not recommended.
5. Elderly Patients:
   • Lower doses may be required due to increased sensitivity to side effects, particularly cardiovascular and renal.

Celecoxib has a significant potential for drug interactions due to its effects on prostaglandin synthesis and metabolism. Key interactions include:

1. Anticoagulants:
   • Celecoxib may enhance the anticoagulant effects of warfarin, increasing the risk of bleeding.
2. ACE Inhibitors and Diuretics:
   • Celecoxib may reduce the efficacy of antihypertensive medications and increase the risk of renal impairment.
3. Lithium:
   • Celecoxib may increase lithium levels, increasing the risk of toxicity.
4. Methotrexate:
   • Celecoxib may increase the levels of methotrexate, increasing the risk of toxicity.
5. Other NSAIDs:
   • Concurrent use with other NSAIDs increases the risk of gastrointestinal and cardiovascular side effects.

Celecoxib is the generic name for this medication. It is marketed under various brand names, depending on the country and manufacturer. Some examples include:

• Celebrex (a well-known brand in the United States and other regions).
• Celecoxib Accord.
• Celecoxib Mylan.
• Celecoxib Sandoz.